Mesenchymal stem cells (multipotent stromal cells; MSCs) have been under investigation for
the treatment of diverse diseases, with many promising outcomes achieved in animal …

Mesenchymal stem cells (MSCs) are multipotent adult cells with self-renewing capacities.
MSCs display specific properties, such as the ability to repair damaged tissues, resulting in …

Epilepsy is a chronic non-infectious disease of the brain, characterized primarily by recurrent
unprovoked seizures, defined as an episode of disturbance of motor, sensory, autonomic, or …

Stem cells are a versatile source for cell therapy. Their use is particularly significant for the
treatment of neurological disorders for which no definitive conventional medical treatment is …

Epilepsy is a life-threatening neurological disease that affects approximately 70 million
people worldwide. Although the vast majority of patients may be successfully managed with …

The current study was conducted to examine an innovative method for synthesizing gold
nanoparticles (AuNPs) from an aqueous sweet granadilla (Passiflora ligularis Juss) P …

The initial precipitating injury such as SE progresses to chronic epilepsy through multiple
epileptogenic processes. Early epileptogenic events are generally characterized by …

Depression poses a significant threat to global physical and mental health, impacting
around 3.8% of the population with a rising incidence. Current treatment options primarily …

Drug‐resistant epilepsy (DRE) is characterized by recurrent seizures despite appropriate
treatment with antiseizure medication (ASM). Due to their regenerative and …

Dravet syndrome (DS) is a form of severe childhood-onset refractory epilepsy typically
caused by a heterozygous loss-of-function mutation. DS patient-derived induced pluripotent …